Filter Results:
(3,950)
Show Results For
- All HBS Web
(3,950)
- People (16)
- News (908)
- Research (2,202)
- Events (10)
- Multimedia (86)
- Faculty Publications (1,674)
Show Results For
- All HBS Web
(3,950)
- People (16)
- News (908)
- Research (2,202)
- Events (10)
- Multimedia (86)
- Faculty Publications (1,674)
- Fast Answer
Turnarounds
bar and load the Screener App. Change the Universe to Private Equity Investments and Entity Type to Investments. In the text box where it says 'Add Filter' type in Fund Stage, select Include, check off... View Details
- 18 Nov 2010
- Research & Ideas
GM’s IPO: Back to the Future
management alike. Bondholders received something like 10-to-15 cents in new GM equity on the dollar when the debt had no market value. The unions received a larger share of the equity than some thought their... View Details
- 01 Sep 2009
- First Look
First Look: September 1
considerations guiding financial reporting. Financial reports produced under the positive theory of GAAP would also generate information useful for equity valuation, but equity valuation is not predicted to... View Details
Keywords: Martha Lagace
- 01 Dec 2009
- News
An Action Plan for Economic Recovery
incentives. The question is, what can we learn from the private equity model? When it comes to megabanks, I’m in favor of a smaller board with deep financial expertise, substantial time commitments, and a different pay structure. We can... View Details
- 21 Nov 2017
- First Look
First Look at New Research and Ideas, November 21, 2017
membership is considered highly prestigious. We document that index-inclusion incentives have led firms to increase return on equity proportionally by 41% on average, via higher margins, efficiency, or shareholder payouts, depending on... View Details
Keywords: Sean Silverthorne
- 01 Dec 1999
- News
African-American Alumni Conference Considers Success and the Bottom Line
Jackson, Sr.; John H. Johnson of Johnson Publishing; Robert Johnson, CEO of Black Entertainment Television; and Stuart Alden Taylor (MBA '87), senior managing director at Bear Stearns. Interactive sessions explored private equity deal... View Details
Keywords: Mary Ellen Gardner
- February 1988 (Revised May 1988)
- Background Note
Note on Debt-Equity Conversions in Latin American Countries
By: Ray A. Goldberg
Goldberg, Ray A. "Note on Debt-Equity Conversions in Latin American Countries." Harvard Business School Background Note 588-063, February 1988. (Revised May 1988.)
- July 2017 (Revised July 2019)
- Supplement
"Doctor My Eyes"--The Acquisition of Bausch & Lomb by Warburg Pincus (B)
By: Nori Gerardo Lietz and Ricardo Andrade
The B Case of "Dr. My Eyes" provides the answer as to what happened after the ending fact pattern in Case A and the imminent choices faced by the protagonist in the primary case. At the end of the Case A, Bess Weatherman of Warburg Pincus, must chose one option of two... View Details
Keywords: Private Equity; Health Care and Treatment; Mergers and Acquisitions; Corporate Governance; Decision Choices and Conditions; Outcome or Result; Health Industry; Consumer Products Industry; Pharmaceutical Industry
Lietz, Nori Gerardo, and Ricardo Andrade. "Doctor My Eyes"--The Acquisition of Bausch & Lomb by Warburg Pincus (B). Harvard Business School Supplement 218-029, July 2017. (Revised July 2019.)
- April 2016 (Revised July 2019)
- Case
"Doctor My Eyes"--The Acquisition of Bausch & Lomb by Warburg Pincus (A)
In early 2010, senior partners at Warburg Pincus met to review a report on Bausch & Lomb Incorporated, the firm's largest investment at the time. Warburg Pincus had led a group of investors in acquiring Bauch & Lomb on October 26, 2007, taking the company private and... View Details
Keywords: Health Care; Mergers ＆ Acquisitions; Governance; Buyout; Private Equity; Finance; Mergers and Acquisitions; Corporate Governance; Health Care and Treatment; Reports; Business Model; Health Industry; Consumer Products Industry; Pharmaceutical Industry; United States
Lietz, Nori Gerardo. "Doctor My Eyes"--The Acquisition of Bausch & Lomb by Warburg Pincus (A). Harvard Business School Case 216-021, April 2016. (Revised July 2019.)
- May 2010 (Revised January 2012)
- Case
Lincoln Financial Meets the Financial Crisis
By: Robert C. Pozen and Peter Goodspeed Spring
In March of 2009, Lincoln Financial Group's CEO Dennis Glass was facing a difficult decision as to how he would replenish his company's capital, which could quickly fall to dangerously low levels as a result of the financial crisis. Though the cost of raising capital... View Details
Keywords: Cost vs Benefits; Financial Crisis; Capital; Private Equity; Crisis Management; Business and Government Relations; Business and Stakeholder Relations; Insurance Industry
Pozen, Robert C., and Peter Goodspeed Spring. "Lincoln Financial Meets the Financial Crisis." Harvard Business School Case 310-137, May 2010. (Revised January 2012.)
- February 2017 (Revised January 2022)
- Supplement
Bankruptcy at Caesars Entertainment (B)
By: Kristin Mugford
Keywords: Gaming; Chapter 11; Fraudulent Conveyance; Apollo; TPG; Bankruptcy; Leveraged Buyouts; Restructuring; Capital Structure; Insolvency and Bankruptcy; Private Equity; Financial Management; Lawsuits and Litigation; Negotiation; Entertainment and Recreation Industry; Las Vegas
Mugford, Kristin. "Bankruptcy at Caesars Entertainment (B)." Harvard Business School Supplement 217-058, February 2017. (Revised January 2022.)
- 2009
- Case
Innovamedica: Innovation in an Emerging Market
By: Roberto Charvel, Fernando Fabre and T. Putimahtama
Innovamedica was a medical start up with several state of the art devices such as a silicon substitute heart and other inventions. However, the founding scientist was struggling in attracting talent and fundraising and that had an impact on growth. View Details
Keywords: Biotech; Entrepreneurial Finance; Entrepreneurship; Start-up; Emergent Countries; Business Startups; Talent and Talent Management; Design; Corporate Entrepreneurship; Private Equity; Health Testing and Trials; Innovation and Invention; Managerial Roles; Biotechnology Industry; Latin America; North and Central America
Charvel, Roberto, Fernando Fabre, and T. Putimahtama. "Innovamedica: Innovation in an Emerging Market." Instituto Panamericano de Alta Dirección de Empresa (IPADE) Case (P)DGe-440, 2009.
- November 2007 (Revised October 2009)
- Case
Ligand Pharmaceuticals Incorporated
In an activist role, the hedge fund Third Point LLC has three board seats and an ownership stake of 9.5% in Ligand Pharmaceuticals, Inc., a specialty pharmaceutical company. Third Point believed that Ligand had a strong drug portfolio and pipeline but that it was... View Details
Keywords: Mergers and Acquisitions; Private Equity; Investment Activism; Investment Funds; Governing and Advisory Boards; Bids and Bidding; Ownership Stake; Pharmaceutical Industry; United States
El-Hage, Nabil N., and Michael Gorzynski. "Ligand Pharmaceuticals Incorporated." Harvard Business School Case 208-019, November 2007. (Revised October 2009.)
William F. Laporte
Laporte grew revenues, earnings, earnings per share and dividends every year of his CEO tenure with return on equity averaging 30% from 1971 to 1981. Laporte built American Home Products through debt-free strategic acquisitions and... View Details
Keywords: Healthcare
Harvey H. Lamm
his tenure, Subaru was rated as one of the best financially managed automobile companies in the United States, regularly achieving 55%+ return on equity ratios. View Details
Keywords: Automotive & Aerospace
- Profile
Akshay Ghulati
eight months he sold many of the holdings to a private equity investor and broke new ground again – as the first non-MBA hired by A.T. Kearney. "I helped them set up an office in Dubai," says Akshay. "Now they've... View Details
Harold V. Haverty
Haverty achieved over 5 consecutive years of 25%+ return on equity ratios and double digit revenue growth. He is credited with diversifying Deluxe – expanding into electronic funds processing from off-line check printing. Haverty was... View Details
Keywords: Finance